Nanoparticle injection developed to treat skin cancer
Researchers from Yale University (CT, USA) have developed a bioadhesive nanoparticle drug delivery system that releases a chemotherapy agent into tumors over time, and have demonstrated the technique in in vitro studies and a mouse model. The treatment may provide an alternative to surgical removal of skin cancer lesions, which is an invasive procedure with the potential for infection and other complications. Michael Girardi (Yale University), senior author of the study, highlighted the importance of a less invasive procedure: "For a lot of patients, treating skin cancer is much more involved than it would be if there was a way...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!
